About Ava Pathways
Ava Pathways is a company based in Vancouver (Canada) founded in 2020 was acquired by BC Craft Supply in January 2021. Ava Pathways operates in a competitive market with competitors including Acticor Biotech, Basking Biosciences, Remedy Pharmaceuticals, Alveron Pharma and Remedium Bio, among others.
- Headquarter Vancouver, Canada
- SectorsHealthcare
- Email••••••••
- Website avapathways.com
- Acquired by BC Craft Supply (Jan 2021)
- Investors
- Acquired byBC Craft Supply
(Jan 2021)
Investors in Ava Pathways
Ava Pathways has secured backing from 1 investor. Prominent investors backing the company include BC Craft Supply.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of support services for the cannabis cultivators such as growing techniques, quality assurance, and facility design among others | 2012 | bccraftsupply.ca | Victoria, Canada |
Investor details for Ava Pathways
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ava Pathways
1 people are tracked at Ava Pathways (1 in leadership).
| Name | Role | Group |
|---|---|---|
Lily Aleksandrova | CEO | Leadership |
Complete people profiles for Ava Pathways
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ava Pathways
2 dated milestones of Ava Pathways across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Ava Pathways is founded.
- Exit Acquired by BC Craft Supply.
Competitors of Ava Pathways
Ava Pathways operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acticor Biotech, Basking Biosciences, Remedy Pharmaceuticals, Alveron Pharma and Remedium Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| acticor-biotech.com | 2013 | Paris, France | $31.36M | – | Immunotherapeutics are developed for ischemic stroke treatment using monoclonal antibodies. | |
| baskingbiosciences.com | 2019 | Columbus, United States | $89.8M | 3 | Therapeutics for ischemic stroke treatment are developed. | |
| remedypharmaceuticals.com | 2004 | New York, United States | $22.76M | 6 | Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury. | |
| alveron.com | 2019 | Nijmegen, Netherlands | $11.79M | – | Drugs for haemorrhagic stroke and intracranial haemorrhage are developed. | |
| remedium-bio.com | 2020 | Needham, United States | $3.5M | – | Gene therapies for immune and age-related conditions are developed. | |
| zzbiotech.com | 2006 | Houston, United States | – | – | Genetically engineered proteins for stroke and brain disorders are developed. | |
| aurumbiosciences.com | 2015 | Glasgow, United Kingdom | $6.3M | 6 | Novel oxygen carriers and MRI software for stroke are developed. | |
| magpiepharma.com | 2016 | Guangzhou, China | $29.14M | – | Developer of small molecules for the treatment of stroke and other heart diseases | |
| snebio.com | 2019 | Seoul, South Korea | $7.34M | – | Cell therapies for neurological disorders are developed using extracellular vesicles. | |
| sinntaxis.com | 2017 | Lund, Sweden | – | – | Small molecule therapeutics for stroke recovery treatment are developed. |
Detailed competitors of Ava Pathways
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Ava Pathways
10 companies that operate in the same segment as Ava Pathways (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ava Pathways
Ava Pathways was founded in 2020.
Ava Pathways is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Lily Aleksandrova is the current CEO of Ava Pathways.
Ava Pathways was established in 2020 in Vancouver, Canada. Focus is placed on research and development of therapeutic solutions targeting post-traumatic stress disorder (PTSD). Treatments are delivered via a clinical network to support patient care. Operations center on the healthcare sector, with activities centered in mental health therapeutics and clinical service provision.
Ava Pathways's top competitors include Acticor Biotech, Remedy Pharmaceuticals and Basking Biosciences.
Ava Pathways has 1 investor. Key investors include BC Craft Supply.
Yes. Ava Pathways was acquired by BC Craft Supply in January 2021.